XML 39 R29.htm IDEA: XBRL DOCUMENT v3.21.2
STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2021
Summary of Stock option and restricted stock activity

A summary of stock option and restricted stock activity under the 2008 Plan and Inducement Grants during the nine months ended September 30, 2021 and 2020 is presented below:

(in thousands)

Options

Inducement Grants

RSAs

Outstanding at December 31, 2019

 

757

192

Granted

 

42

180

305

Options Exercised/RSAs Vested

 

(8)

(128)

 (1)

Forfeited

 

(44)

(17)

Expired

 

Outstanding at September 30, 2020

 

747

180

352

Outstanding at December 31, 2020

 

756

180

352

Granted

 

97

61

463

Options Exercised/RSAs Vested

 

(5)

(126)

 (2)

Forfeited

 

(74)

(61)

Expired

 

Outstanding at September 30, 2021

 

774

241

628

(1)Includes 43 thousand shares purchased from employees to cover employee income taxes related to income earned upon vesting of restricted stock. The shares purchased are held in treasury and the $1.5 million total purchase price for the shares is included in Treasury stock in our accompanying unaudited interim condensed consolidated balance sheets.
(2)Includes 28 thousand shares purchased from employees to cover employee income taxes related to income earned upon vesting of restricted stock. The shares purchased are held in treasury and the $0.9 million total purchase price for the shares is included in Treasury stock in our accompanying unaudited interim condensed consolidated balance sheets.
Employee Stock Purchase Plan 2016 [Member]  
Summary of allocated expense

(in thousands)

Three Months Ended September 30, 

Nine Months Ended September 30, 

    

2021

    

2020

    

2021

    

2020

    

Cost of sales

$

3

$

3

$

11

$

14

Research and development

 

5

 

6

 

16

 

25

Selling, general, and administrative

 

20

 

23

 

66

 

79

$

28

$

32

$

93

$

118

Stock Incentive Plan 2008 [Member]  
Summary of allocated expense

Three Months Ended September 30, 

Nine Months Ended September 30, 

(in thousands)

    

2021

    

2020

    

2021

    

2020

    

Cost of sales

$

2

$

34

$

4

$

93

Research and development

 

144

 

117

 

407

 

450

Selling, general, and administrative

 

2,634

 

2,200

 

7,017

 

9,882

$

2,780

$

2,351

$

7,428

$

10,425